Further GSEA using previously published gene signature by selective estrogen receptor modulator (SERM) or selective estrogen receptor degrader (SERD) (28) showed that downregulated gene signature by SERM or SERD was enriched in melanoma ICB-responders (Figure 4B, Supplementary Figure 4, Supplementary Table 9). The gene discussed is ESR1; the disease is melanoma.